Concepedia

Author

Marc Bourcier

Centre de Recherche Dermatologique du Québec MétropolitainORCID

Also Known As

Bourcier, M., M. Bourcier, Marc Bourcier, P. Barlow

60

Publications

2.4K

Citations

26

H-Index

46

Concepts

All Affiliations

Centre de Recherche Dermatologique du Québec MétropolitainMoncton HospitalUniversity of TorontoUniversité de SherbrookeInnovaderm (Canada)
MB

About

Marc Bourcier is an author at Centre de Recherche Dermatologique du Québec Métropolitain specializing in medicine, dermatology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

512

2

Obstetrics

3

3

104

3

Public Health

2

2

74

4

Allergy

2

2

219

5

Immunology

1

1

197

Marc Bourcier

×

25

Publications

1.5K

Citations

21

H-Index

YearCitations

Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council

Bruce Strober, Caitriona Ryan, Peter van de Kerkhof,

Journal of the American Academy of Dermatology

2019

226

Evidence that a neutrophil–keratinocyte crosstalk is an early target of <scp>IL</scp>‐17A inhibition in psoriasis

Kristian Reich, Kim Papp, Robert Matheson,

Experimental Dermatology

2015

197

Ustekinumab improves nail disease in patients with moderate‐to‐severe psoriasis: results from <scp>PHOENIX</scp> 1

Phoebe Rich, Marc Bourcier, Howard Sofen,

British Journal of Dermatology

2013

110

Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population

Kim Papp, Yves Poulin, Robert Bissonnette,

Journal of the American Academy of Dermatology

2010

100

A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp Psoriasis

Thomas A. Luger, F. Cambazard, Frederik Grønhøj Larsen,

Dermatology

2008

93

Clinical Goals and Barriers to Effective Psoriasis Care

Bruce Strober, Joelle M. van der Walt, April W. Armstrong,

Dermatology and Therapy

2018

91

Impact of ustekinumab on health‐related quality of life and sexual difficulties associated with psoriasis: results from two phase III clinical trials

Lyn Guenther, Chenglong Han, Philippe Szapary,

Journal of the European Academy of Dermatology and Venereology

2011

71

Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use.

Carrie Brodmerkel, Eric Wadman, Richard G. Langley,

PubMed

2013

69

Early relapse of psoriasis after stopping brodalumab: a retrospective cohort study in 77 patients

M. Masson Regnault, M.P. Konstantinou, A. Khemis,

Journal of the European Academy of Dermatology and Venereology

2017

69

Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: Results from PHOENIX 2

Kristian Reich, Brad Schenkel, N. Zhao,

Journal of Dermatological Treatment

2010

49

Page 1